Intestinal Infection

2

Review clinical trials related to Intestinal Infection. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Rescue Fecal Microbiota Transplantation for National Refractory Intestinal Infections

A national data registry of patients receiving the rescue fecal microbiota transplantation for the refractory intestinal infections from the China Microbiota Transplantation System was designed to assess the short-term and long-term safety and efficacy.

Participants needed: 100
Trial details
Biological sex: AllType: ObservationalSponsor: The Second Hospital of Nanjing Medical UniversityUpdated: Feb 29, 2024Locations: 1
Eligibility criteria

Not listed

Status: Not yet recruiting

MAL-ED Metabolic: A Follow-Up of Chronic Disease at Puberty

The concept that the roots of cardiometabolic disease start in early life was established by Dr. David Barker, who documented relationships between low birthweight (as a marker for challenges during gestation) and later cardiovascular disease (CVD). Later work has suggested that post-natal challenges (similar to prenatal ones) may also exhibit links to later cardiometabolic disease, with the strongest links appearing to be between low weight in early childhood and later hypertension and high waist circumference (WC). However, assessments for the relationship between early childhood challenges and insulin resistance and glucose regulation have been lacking and long-term cohort studies are few. In this project, we aim to assess children initially followed as part of The Etiology, Risk Factors, and Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health (MAL-ED) study, where they received frequent measures of anthropometry and laboratory assessments for intestinal pathogens. These children are now of peri-pubertal age--a time period associated with metabolic shifts. We will assess for glucose dysregulation and findings associated with the metabolic syndrome, and we will analyze potential associations between current chronic disease risk findings with early life poor growth and intestinal pathogen carriage rate. As such, we hope to uncover potential targets in early life health to reduce later chronic disease risk.

Participants needed: 254
Trial details
Age: 9-17Biological sex: AllType: ObservationalSponsor: University of VirginiaUpdated: Nov 16, 2021
Eligibility criteria

Participated in original MAL-ED cohort

Did not participate in original MAL-ED cohort